WAKEFIELD, Mass., Oct. 15, 2020 /PRNewswire/ -- Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading vertically integrated multi-state cannabis operator in the United States, today announced the launch of its latest collection of vape cartridges, Curaleaf Live Blends, in Florida. A first of its kind product in the industry, Live Blends are formulated with a proprietary blend of live and botanical terpenes that deliver a flavor and experience not seen before.
By combining the benefits of live terpenes and the flavor of natural botanicals, Curaleaf Live Blends provide an optimized experience in both taste and effect. Each cartridge combines the strain-specific Solventless Terpene Extract (STE) of freshly harvested cannabis with a micro-infusion of botanical terpenes. This unique process results in the cleanest and broadest spectrum of live terpenes and other fragrant cannabis compounds. The premium distillate features an enhanced experience in flavor and result.
"Florida is the first market in the country to offer our premium Live Blends products as we aim to help a wider group of patients find relief through these flavorful and efficient cartridges," said Joe Bayern, President of Curaleaf. "Our patient-first approach to the R&D process has garnered positive reviews for our recently debuted NANO Drops, first-to-Florida market Sublingual tablets, and Select Elite Live cartridges that launched in the state earlier this year. We are proud to debut another innovative product to the patients of Florida."
Live Blends products feature fruitier and more approachable flavor profiles that are expertly paired with strains for an optimal consumption experience. This product line is ideal for patients who prefer a sweeter taste experience and those interested in trying live terpene vape cartridges but who may be unaccustomed to the intense cannabis flavors often found in conventional live products.
Curaleaf Live Blends are launching five unique hybrid strains to medical patients across the state to start, with additional combinations to debut in the coming months.
Florida is a fast-growing medical cannabis market. Currently, there are more than 420,000 medical patients enrolled in the Florida program - about 1.7% of the state's population - with approximately 5,000 new patients joining each week. Live Blends is the fourth product to enter Curaleaf Florida's medical market this year, after its Sublingual Tablets, Select Elite Live cartridges, and Curaleaf NANO Drops. For more information on Curaleaf's dispensary locations in Florida, please visit https://curaleaf.com/locations/#florida.
To learn more about Curaleaf, visit their profile page.
View the original press release here.
About Curaleaf Holdings, Inc.
Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) ("Curaleaf") is a leading vertically integrated U.S. multi-state cannabis operator with a mission to improve lives by providing clarity around cannabis and confidence around consumption. As a high-growth cannabis company known for quality, expertise and reliability, the company and its brands, including Curaleaf and Select, provide industry-leading service, product selection and accessibility across the medical and adult-use markets. Curaleaf currently operates in 23 states with 95 dispensaries, 22 cultivation sites and over 30 processing sites, and employs over 3,000 people across the United States. Curaleaf is listed on the Canadian Securities Exchange under the symbol CURA and trades on the OTCQX market under the symbol CURLF. For more information please visit http://www.curaleaf.com.